TransEnterix (TRXC) : The most positive equity analysts on TransEnterix (TRXC) expects the shares to touch $4, whereas, the least positive believes that the stock will trade at $2 in the short term. The company is covered by 4 Wall Street Brokerage Firms. The average price target for shares are $3.19 with an expected fluctuation of $0.9 from the mean.
TransEnterix (TRXC) : 4 analysts are covering TransEnterix (TRXC) and their average rating on the stock is 1.75, which is read as a Buy. 2 equity analysts believe that the stock has a bright future and the price doesnt capture all of its upside, hence they rate the stock as a Strong Buy. TransEnterix (TRXC) also receives 1 more Buy recommendations from analysts who believe that the stock will do well going forward. A Zacks Investment Research rank of 2, which recommends a Buy affirms that they expect a large upside in the stock from the current levels. A total of 1 brokerage firms believe that the stock is fairly valued, hence they advise a Hold on the stock.
TransEnterix (NYSEMKT:TRXC): The stock was completely flat for the day, closing at $1.37 on Thursday. The flat closing masks the intraday volatility in the stock. After opening at $1.38, the stock touched an intraday high of $1.39 and a low of $1.35. Neither the bulls nor the bears asserted their supremacy at close, due to which the stock closed completely flat. The stock previously closed at $1.37. The total trading volume on Thursday was 363,970.
TransEnterix, Inc. is a medical device company focused on the development and commercialization of a robotic assisted surgical system called the SurgiBot System (the SurgiBot System). The Companys SurgiBot System is designed to utilize flexible instruments through articulating channels controlled directly by the surgeon with robotic assistance while the surgeon remains patientside within the sterile field. It has commercialized the SPIDER Surgical System, (the SPIDER System) a manual laparoscopic system in the United States, Europe and the Middle East. The SPIDER System utilizes flexible instruments and articulating channels that are controlled directly by the surgeon, allowing for multiple instruments to be introduced through a single site. It also offers Flex Ligating Shears (FLS) which is an energy device used with the existing SPIDER Surgical System. The FLS device is designed to deliver controlled energy to ligate and divide tissue.